Non-invasive Brain Stimulation for Auditory Verbal Hallucinations in Schizophrenia
NCT ID: NCT01801787
Last Updated: 2016-08-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
30 participants
INTERVENTIONAL
2013-03-31
2015-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Transcranial Current Stimulation as a Treatment for Auditory Hallucinations in Schizophrenia
NCT01963676
Transcranial Direct Current Stimulation and Effects on Early Auditory Processing in Schizophrenia
NCT03537703
Effect of Neuroplasticity Modulation in tDCS Treatment Response Among Schizophrenia Patients With Auditory Hallucination
NCT04629352
Remediation of Auditory Recognition in Schizophrenia With tDCS
NCT02869334
Improving Cognition in Schizophrenia Using Non-invasive Brain Stimulation
NCT04184830
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
verum tDCS
left-hemispheric tDCS: anode placed midway between F3 and FP1, cathode placed midway between T3 and P3
tDCS
active vs. sham tDCS left hemisphere
sham tDCS
left-hemispheric sham tDCS: anode placed midway between F3 and FP1, cathode placed midway between T3 and P3
tDCS
active vs. sham tDCS left hemisphere
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
tDCS
active vs. sham tDCS left hemisphere
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* chronic auditory verbal hallucinations
* right-handed
Exclusion Criteria
* severe cognitive deficits
* severe medical conditions
* severe neurological disorders
* severe microangiopathy
* history of electroconvulsive therapy
* pregnancy or lactation
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Charite University, Berlin, Germany
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Andres Neuhaus, MD
M.D.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Robert Lindenberg, MD
Role: PRINCIPAL_INVESTIGATOR
Department of Neurology, Charité University Medicine Berlin
Andres H. Neuhaus, MD
Role: PRINCIPAL_INVESTIGATOR
Department of Psychiatry, Charité University Medicine Berlin
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Charité University Medicine
Berlin, , Germany
Charité University Medicine
Berlin, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EA4/123/12
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.